HEADER CONTRACTILE PROTEIN 30-SEP-20 7KAA TITLE NMR SOLUTION STRUCTURES OF TIRASEMTIV DRUG BOUND TO A FAST SKELETAL TITLE 2 TROPONIN C-TROPONIN I COMPLEX COMPND MOL_ID: 1; COMPND 2 MOLECULE: TROPONIN C, SKELETAL MUSCLE,TROPONIN I, FAST SKELETAL COMPND 3 MUSCLE CHIMERA; COMPND 4 CHAIN: A; COMPND 5 SYNONYM: TROPONIN I,FAST-TWITCH ISOFORM; COMPND 6 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: TNNC2, TNNI2; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS ACTIVATOR, CONTRACTILE PROTEIN EXPDTA SOLUTION NMR NUMMDL 25 AUTHOR P.MERCIER,M.X.LI,J.J.HARTMAN,B.D.SYKES REVDAT 3 14-JUN-23 7KAA 1 REMARK REVDAT 2 07-APR-21 7KAA 1 JRNL REVDAT 1 24-MAR-21 7KAA 0 JRNL AUTH M.X.LI,P.MERCIER,J.J.HARTMAN,B.D.SYKES JRNL TITL STRUCTURAL BASIS OF TIRASEMTIV ACTIVATION OF FAST SKELETAL JRNL TITL 2 MUSCLE. JRNL REF J.MED.CHEM. V. 64 3026 2021 JRNL REFN ISSN 0022-2623 JRNL PMID 33703886 JRNL DOI 10.1021/ACS.JMEDCHEM.0C01412 REMARK 2 REMARK 2 RESOLUTION. NOT APPLICABLE. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : X-PLOR NIH REMARK 3 AUTHORS : SCHWIETERS, KUSZEWSKI, TJANDRA AND CLORE REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: WATER REFINEMENT REMARK 4 REMARK 4 7KAA COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 01-OCT-20. REMARK 100 THE DEPOSITION ID IS D_1000251655. REMARK 210 REMARK 210 EXPERIMENTAL DETAILS REMARK 210 EXPERIMENT TYPE : NMR REMARK 210 TEMPERATURE (KELVIN) : 298 REMARK 210 PH : 6.7 REMARK 210 IONIC STRENGTH : 200 REMARK 210 PRESSURE : 1 ATM REMARK 210 SAMPLE CONTENTS : 0.5 MM [U-13C; U-15N] TROPONINC REMARK 210 -TROPONIN I CHIMERA, 10 MM REMARK 210 IMIDAZOLE, 100 MM KCL, 90% H2O/ REMARK 210 10% D2O REMARK 210 REMARK 210 NMR EXPERIMENTS CONDUCTED : 2D 1H-15N HSQC NH2 ONLY; 2D 1H REMARK 210 -13C HSQC AROMATIC; 3D CBCA(CO) REMARK 210 NH; 3D HNCACB; 3D C(CO)NH; 3D REMARK 210 H(CCO)NH; 3D 1H-13C NOESY REMARK 210 ALIPHATIC; 3D 1H-15N NOESY REMARK 210 ALIPHATIC; 3D 1H-13C NOESY REMARK 210 CNFILTERED; 2D 1H-15N HSQC REMARK 210 CNFILTERED REMARK 210 SPECTROMETER FIELD STRENGTH : 800 MHZ; 600 MHZ REMARK 210 SPECTROMETER MODEL : INOVA REMARK 210 SPECTROMETER MANUFACTURER : VARIAN REMARK 210 REMARK 210 STRUCTURE DETERMINATION. REMARK 210 SOFTWARE USED : VNMRJ 3.2, NMRPIPE, NMRVIEWJ, REMARK 210 CYANA 2.1 REMARK 210 METHOD USED : SIMULATED ANNEALING REMARK 210 REMARK 210 CONFORMERS, NUMBER CALCULATED : 100 REMARK 210 CONFORMERS, NUMBER SUBMITTED : 25 REMARK 210 CONFORMERS, SELECTION CRITERIA : STRUCTURES WITH THE LOWEST REMARK 210 ENERGY REMARK 210 REMARK 210 BEST REPRESENTATIVE CONFORMER IN THIS ENSEMBLE : 1 REMARK 210 REMARK 210 REMARK: NULL REMARK 215 REMARK 215 NMR STUDY REMARK 215 THE COORDINATES IN THIS ENTRY WERE GENERATED FROM SOLUTION REMARK 215 NMR DATA. PROTEIN DATA BANK CONVENTIONS REQUIRE THAT REMARK 215 CRYST1 AND SCALE RECORDS BE INCLUDED, BUT THE VALUES ON REMARK 215 THESE RECORDS ARE MEANINGLESS. REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 HZ3 LYS A 56 OD2 ASP A 60 1.54 REMARK 500 HH21 ARG A 12 OE1 GLU A 77 1.56 REMARK 500 OE2 GLU A 64 HD1 HIS A 148 1.57 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 1 MET A 4 99.49 -68.15 REMARK 500 1 ASP A 31 90.27 64.21 REMARK 500 1 ASP A 33 18.71 -153.54 REMARK 500 1 PRO A 54 -151.12 -92.80 REMARK 500 1 ASP A 75 -160.17 -160.99 REMARK 500 1 LYS A 106 46.09 -81.04 REMARK 500 1 PRO A 109 -158.92 -73.60 REMARK 500 1 ARG A 111 -1.28 64.93 REMARK 500 1 LYS A 130 -16.84 -140.42 REMARK 500 1 LEU A 139 46.95 -80.34 REMARK 500 1 HIS A 150 142.36 -174.18 REMARK 500 2 ASP A 33 -73.18 -162.65 REMARK 500 2 SER A 71 121.93 -175.09 REMARK 500 2 ARG A 102 -68.35 -134.34 REMARK 500 2 PRO A 109 -166.39 -67.81 REMARK 500 2 LEU A 110 39.72 -80.22 REMARK 500 2 ARG A 112 94.46 -68.18 REMARK 500 2 ARG A 114 98.82 -68.35 REMARK 500 2 HIS A 147 101.67 -177.94 REMARK 500 3 THR A 5 104.54 53.08 REMARK 500 3 ASP A 31 80.64 57.83 REMARK 500 3 ASP A 33 -59.70 -173.41 REMARK 500 3 SER A 39 -168.67 -128.00 REMARK 500 3 THR A 53 93.31 -161.42 REMARK 500 3 PRO A 54 -77.74 -89.66 REMARK 500 3 SER A 71 -175.40 -178.83 REMARK 500 3 ALA A 94 -64.36 70.37 REMARK 500 3 PHE A 99 -50.55 -155.97 REMARK 500 3 PRO A 109 -167.83 -70.83 REMARK 500 3 SER A 127 -37.38 73.14 REMARK 500 3 ASN A 138 -155.85 -131.08 REMARK 500 3 LYS A 144 -166.04 -101.73 REMARK 500 3 HIS A 147 82.95 -164.50 REMARK 500 4 ASP A 31 81.23 60.00 REMARK 500 4 ASP A 33 -33.48 -148.70 REMARK 500 4 THR A 53 102.19 -163.89 REMARK 500 4 PRO A 54 -81.10 -71.62 REMARK 500 4 SER A 71 109.63 -167.73 REMARK 500 4 VAL A 113 117.19 179.86 REMARK 500 4 LYS A 130 -25.21 -144.08 REMARK 500 4 LEU A 139 -71.62 -93.41 REMARK 500 4 GLU A 145 49.50 -78.66 REMARK 500 5 ASP A 31 85.19 62.46 REMARK 500 5 ASP A 33 -46.99 78.97 REMARK 500 5 THR A 53 104.50 -164.54 REMARK 500 5 PRO A 54 -142.24 -85.87 REMARK 500 5 GLU A 68 16.82 -141.66 REMARK 500 5 SER A 71 117.51 -165.02 REMARK 500 5 LEU A 98 -166.13 -110.41 REMARK 500 5 ARG A 112 34.41 -89.26 REMARK 500 REMARK 500 THIS ENTRY HAS 270 RAMACHANDRAN OUTLIERS. REMARK 500 REMARK 500 REMARK: NULL REMARK 620 REMARK 620 METAL COORDINATION REMARK 620 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 620 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 CA A 201 CA REMARK 620 N RES CSSEQI ATOM REMARK 620 1 ASP A 67 OD1 REMARK 620 2 ASP A 69 OD1 78.1 REMARK 620 3 ASP A 69 OD2 107.1 45.4 REMARK 620 4 SER A 71 O 74.1 119.0 94.4 REMARK 620 5 THR A 73 OG1 141.7 139.9 106.6 85.7 REMARK 620 6 GLU A 78 OE1 84.1 67.9 105.0 154.3 104.1 REMARK 620 N 1 2 3 4 5 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 30801 RELATED DB: BMRB REMARK 900 NMR SOLUTION STRUCTURES OF TIRASEMTIV DRUG BOUND TO A FAST SKELETAL REMARK 900 TROPONIN C-TROPONIN I COMPLEX. DBREF 7KAA A 4 91 UNP P02585 TNNC2_HUMAN 1 88 DBREF 7KAA A 97 146 UNP P48788 TNNI2_HUMAN 99 148 SEQADV 7KAA MET A 1 UNP P02585 INITIATING METHIONINE SEQADV 7KAA ALA A 2 UNP P02585 EXPRESSION TAG SEQADV 7KAA SER A 3 UNP P02585 EXPRESSION TAG SEQADV 7KAA GLY A 92 UNP P02585 LINKER SEQADV 7KAA GLY A 93 UNP P02585 LINKER SEQADV 7KAA ALA A 94 UNP P02585 LINKER SEQADV 7KAA GLY A 95 UNP P02585 LINKER SEQADV 7KAA GLY A 96 UNP P02585 LINKER SEQADV 7KAA HIS A 147 UNP P48788 EXPRESSION TAG SEQADV 7KAA HIS A 148 UNP P48788 EXPRESSION TAG SEQADV 7KAA HIS A 149 UNP P48788 EXPRESSION TAG SEQADV 7KAA HIS A 150 UNP P48788 EXPRESSION TAG SEQADV 7KAA HIS A 151 UNP P48788 EXPRESSION TAG SEQADV 7KAA HIS A 152 UNP P48788 EXPRESSION TAG SEQRES 1 A 152 MET ALA SER MET THR ASP GLN GLN ALA GLU ALA ARG SER SEQRES 2 A 152 TYR LEU SER GLU GLU MET ILE ALA GLU PHE LYS ALA ALA SEQRES 3 A 152 PHE ASP MET PHE ASP ALA ASP GLY GLY GLY ASP ILE SER SEQRES 4 A 152 VAL LYS GLU LEU GLY THR VAL MET ARG MET LEU GLY GLN SEQRES 5 A 152 THR PRO THR LYS GLU GLU LEU ASP ALA ILE ILE GLU GLU SEQRES 6 A 152 VAL ASP GLU ASP GLY SER GLY THR ILE ASP PHE GLU GLU SEQRES 7 A 152 PHE LEU VAL MET MET VAL ARG GLN MET LYS GLU ASP ALA SEQRES 8 A 152 GLY GLY ALA GLY GLY LYS LEU PHE ASP LEU ARG GLY LYS SEQRES 9 A 152 PHE LYS ARG PRO PRO LEU ARG ARG VAL ARG MET SER ALA SEQRES 10 A 152 ASP ALA MET LEU LYS ALA LEU LEU GLY SER LYS HIS LYS SEQRES 11 A 152 VAL CYS MET ASP LEU ARG ALA ASN LEU LYS GLN VAL LYS SEQRES 12 A 152 LYS GLU ASP HIS HIS HIS HIS HIS HIS HET CA A 201 1 HET W97 A 202 31 HETNAM CA CALCIUM ION HETNAM W97 6-ETHYNYL-1-(PENTAN-3-YL)-1H-IMIDAZO[4,5-B]PYRAZIN-2-OL FORMUL 2 CA CA 2+ FORMUL 3 W97 C12 H14 N4 O HELIX 1 AA1 ASP A 6 TYR A 14 1 9 HELIX 2 AA2 SER A 16 LYS A 24 1 9 HELIX 3 AA3 ALA A 25 ASP A 31 1 7 HELIX 4 AA4 SER A 39 LEU A 50 1 12 HELIX 5 AA5 THR A 55 GLU A 65 1 11 HELIX 6 AA6 ASP A 75 GLY A 93 1 19 HELIX 7 AA7 SER A 116 LEU A 125 1 10 LINK OD1 ASP A 67 CA CA A 201 1555 1555 1.96 LINK OD1 ASP A 69 CA CA A 201 1555 1555 3.05 LINK OD2 ASP A 69 CA CA A 201 1555 1555 1.96 LINK O SER A 71 CA CA A 201 1555 1555 2.17 LINK OG1 THR A 73 CA CA A 201 1555 1555 1.99 LINK OE1 GLU A 78 CA CA A 201 1555 1555 1.96 CRYST1 1.000 1.000 1.000 90.00 90.00 90.00 P 1 1 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 1.000000 0.000000 0.000000 0.00000 SCALE2 0.000000 1.000000 0.000000 0.00000 SCALE3 0.000000 0.000000 1.000000 0.00000 MODEL 1